top of page

NCI-2015-00014

Updated: Feb 21

I-SPY TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2.


This research study aims to predict how well different cancer treatments will work for individual patients. They do this by using advanced imaging techniques and analyzing the patient's cancer cells at a molecular level. By understanding these details, doctors hope to better predict how patients will respond to different treatments, leading to more effective and personalized care.


For more information about the trial, click the link below:

Clinical Trial Site: Einstein/Columbia


To see all available clinical trials click here.



 
 
 

Recent Posts

See All
NCI-2025-04391

A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy andSafety of Olomorasib in Combination with Standard of Care Immunotherapy in Participants withResected or Unresec

 
 
 
NCI-2025-05085

A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB1305 in Participants with Advanced/Metastatic Solid Tumors This Phase 2 , multicenter, open-label research study i

 
 
 
NCI-2025-07002

A Phase 1b, Two-Part Study of Tolododekin Alfa (ANK-101) in Combination with an Anti-PD-1/PD-L1 Antibody in Participants with Advanced Non-Small Cell Lung Cancer This Phase 1b, two-part research study

 
 
 

Comments


bottom of page